Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent mechanism

Pharmacology Biochemistry and Behavior

Volumn 119, Issue , 2014, Pages 72-79

  Zanos, Panos ^a   Wright, Sherie R ^a   Georgiou, Polymnia ^a   Yoo, Ji Hoon ^a   Ledent, Catherine ^b   Hourani, Susanna M ^a   Kitchen, Ian ^a   Winsky Sommerer, Raphaelle ^a   Bailey, Alexis ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Amygdala; Hypothalamus; Methamphetamine; Oxytocin

Indexed keywords

ADENOSINE A2A RECEPTOR; ARGIPRESTOCIN; IODINE 125; METHAMPHETAMINE; OXYTOCIN RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; EMOTIONALITY; FEMALE; GENOTYPE; HYPOTHALAMUS; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SOCIAL BONDING; STRESS; UPREGULATION;

ANIMALIA; MUS; RODENTIA;

A(2A) RECEPTOR; AMYGDALA; HYPOTHALAMUS; METHAMPHETAMINE; OXYTOCIN;

AMYGDALA; ANIMALS; FEMALE; HYPOTHALAMUS; MALE; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A2A; RECEPTORS, OXYTOCIN; UP-REGULATION;

EID: 84895516045     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.05.009     Document Type: Article

References (84)

1. B.J. Aragona, Y. Liu, J.T. Curtis, F.K. Stephan, and Z. Wang A critical role for nucleus accumbens dopamine in partner-preference formation in male prairie voles J Neurosci 23 2003 3483 3490
2. 2A receptor gene J Neurosci 22 2002 9210 9220
3. A. Bailey, H. Matthes, B. Kieffer, S. Slowe, S.M. Hourani, and I. Kitchen Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the mu-opioid receptor gene Brain Res 943 2002 68 79
4. A. Bailey, R.M. Hawkins, S.M. Hourani, and I. Kitchen Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice Br J Pharmacol 139 2003 1187 1195
5. 2A adenosine receptor knockout mice J Neurochem 88 2004 827 834
6. A. Bailey, D. Weber, A. Zimmer, A.M. Zimmer, S.M. Hourani, and I. Kitchen Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains of mice deficient in the preproenkephalin gene Brain Res 1025 2004 1 9
7. S.J. Baracz, P.I. Rourke, M.C. Pardey, G.E. Hunt, I.S. McGregor, and J.L. Cornish Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference Behav Brain Res 228 2012 185 193
8. T.A. Baskerville, and A.J. Douglas Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders CNS Neurosci Ther 16 2010 92 123
9. T. Baumgartner, M. Heinrichs, A. Vonlanthen, U. Fischbacher, and E. Fehr Oxytocin shapes the neural circuitry of trust and trust adaptation in humans Neuron 58 2008 639 650
10. J.H. Broadbear, B. Tunstall, and K. Beringer Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, ÊecstasyÊ) using a drug discrimination paradigm in the rat Addict Biol 16 2011 202 214
11. P. Campbell, A.G. Ophir, and S.M. Phelps Central vasopressin and oxytocin receptor distributions in two species of singing mice J Comp Neurol 516 2009 321 333
12. D.S. Carson, J.L. Cornish, A.J. Guastella, G.E. Hunt, and I.S. McGregor Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats Neuropharmacology 58 2010 38 43
13. D.S. Carson, G.E. Hunt, A.J. Guastella, L. Barber, J.L. Cornish, and J.C. Arnold et al. Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus Addict Biol 15 2010 448 463
14. C.S. Carter Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav Brain Res 176 2007 170 186
15. D. Ciccarone Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy Prim Care 38 2011 41 58
16. S. Clarke, A. Zimmer, A.M. Zimmer, R.G. Hill, and I. Kitchen Region selective up-regulation of m-, d- and k-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice Neuroscience 122 2003 479 489
17. K.J. Clemens, P.S. Van Nieuwenhuyzen, K.M. Li, J.L. Cornish, G.E. Hunt, and I.S. McGregor MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat Psychopharmacology (Berl) 173 2004 318 325
18. K.J. Clemens, J.L. Cornish, G.E. Hunt, and I.S. McGregor Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats Drug Alcohol Depend 86 2007 183 190
19. J.P. Curley, S. Davidson, P. Bateson, and F.A. Champagne Social enrichment during postnatal development induces transgenerational effects on emotional and reproductive behavior in mice Front Behav Neurosci 3 2009 25
20. J. Dabrowska, R. Hazra, T.H. Ahern, J.D. Guo, A.J. McDonald, and F. Mascagni et al. Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: implications for balancing stress and affect Psychoneuroendocrinology 36 2011 1312 1326
21. S. Dawe, P. Davis, K. Lapworth, and R. McKetin Mechanisms underlying aggressive and hostile behavior in amphetamine users Curr Opin Psychiatry 22 2009 269 273
22. J. Debiec Peptides of love and fear: vasopressin and oxytocin modulate the integration of information in the amygdala Bioessays 27 2005 869 873
23. M. Di Simplicio, R. Massey-Chase, P.J. Cowen, and C.J. Harmer Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers J Psychopharmacol 23 2009 241 248
24. G. Domes, M. Heinrichs, J. Glascher, C. Buchel, D.F. Braus, and S.C. Herpertz Oxytocin attenuates amygdala responses to emotional faces regardless of valence Biol Psychiatry 62 2007 1187 1190
25. 2A receptor in mouse brain using the selective antagonist [3H]SCH 58261 Eur J Neurosci 14 2001 1567 1570
26. M. Febo, M. Numan, and C.F. Ferris Functional magnetic resonance imaging shows oxytocin activates brain regions associated with mother-pup bonding during suckling J Neurosci 25 2005 11637 11644
27. M. Febo, J. Shields, C.F. Ferris, and J.A. King Oxytocin modulates unconditioned fear response in lactating dams: an fMRI study Brain Res 1302 2009 183 193
28. S. Ferre, I. Diamond, S.R. Goldberg, L. Yao, S.M. Hourani, and Z.L. Huang et al. Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain Prog Neurobiol 83 2007 332 347
29. S. Ferre, C. Quiroz, A.S. Woods, R. Cunha, P. Popoli, and F. Ciruela et al. An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors Curr Pharm Des 14 2008 1468 1474
30. K.B.J. Franklin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic San Diego
31. K. Fuxe, D.O. Borroto-Escuela, W. Romero-Fernandez, F. Ciruela, P. Manger, and G. Leo et al. On the role of volume transmission and receptor-receptor interactions in social behaviour: focus on central catecholamine and oxytocin neurons Brain Res 1476 2012 119 131
32. G. Gimpl, and F. Fahrenholz The oxytocin receptor system: structure, function, and regulation Physiol Rev 81 2001 629 683
33. C. Goeldner, P.E. Lutz, E. Darcq, T. Halter, D. Clesse, and A.M. Ouagazzal et al. Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine Biol Psychiatry 69 2011 236 244
34. K. Golembiowska, and A. Zylewska Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum Brain Res 806 1998 202 209
35. R. Gonzales, L. Mooney, and R.A. Rawson The methamphetamine problem in the United States Annu Rev Public Health 31 2010 385 398
36. K.M. Grant, T.D. LeVan, S.M. Wells, M. Li, S.F. Stoltenberg, and H.E. Gendelman et al. Methamphetamine-associated psychosis J Neuroimmune Pharmacol 7 2012 113 139
37. M. Heinrichs, and J. Gaab Neuroendocrine mechanisms of stress and social interaction: implications for mental disorders Curr Opin Psychiatry 20 2007 158 162
38. T.M. Jarrett, M.S. McMurray, C.H. Walker, and J.M. Johns Cocaine treatment alters oxytocin receptor binding but not mRNA production in postpartum rat dams Neuropeptides 40 2006 161 167
39. J.M. Johns, D.A. Lubin, C.H. Walker, P. Joyner, C. Middleton, and V. Hofler et al. Gestational treatment with cocaine and fluoxetine alters oxytocin receptor number and binding affinity in lactating rat dams Int J Dev Neurosci 22 2004 321 328
40. E.B. Keverne, and J.P. Curley Vasopressin, oxytocin and social behaviour Curr Opin Neurobiol 14 2004 777 783
41. Y.T. Kim, H.J. Song, J.H. Seo, J.J. Lee, J. Lee, and D.H. Kwon et al. The differences in neural network activity between methamphetamine abusers and healthy subjects performing an emotion-matching task: functional MRI study NMR Biomed 24 2011 1392 1400
42. P. Kirsch, C. Esslinger, Q. Chen, D. Mier, S. Lis, and S. Siddhanti et al. Oxytocin modulates neural circuitry for social cognition and fear in humans J Neurosci 25 2005 11489 11493
43. I. Kitchen, S. Slowe, H. Matthes, and B. Kieffer Quantitative autoradiographic mapping of m, d and k opioid receptors in knockout mice lacking the m-opioid receptor gene Brain Res 778 1997 73 88
44. G.L. Kovacs, F. Laczi, M. Vecsernyes, K. Hodi, G. Telegdy, and F.A. Laszlo Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence Exp Brain Res 65 1987 307 311
45. G.L. Kovacs, Z. Sarnyai, and G. Szabo Oxytocin and addiction: a review Psychoneuroendocrinology 23 1998 945 962
46. I.N. Krasnova, and J.L. Cadet Methamphetamine toxicity and messengers of death Brain Res Rev 60 2009 379 407
47. C. Ledent, J.M. Vaugeois, S.N. Schiffmann, T. Pedrazzini, M. El Yacoubi, and J.J. Vanderhaeghen et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor Nature 388 1997 674 678
48. J.H. Liang, K. Wang, H.L. Sun, and R. Han Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice Psychopharmacology 185 2006 1 10
49. M.M. Lim, A.Z. Murphy, and L.J. Young Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster) J Comp Neurol 468 2004 555 570
50. Y. Liu, K.A. Young, J.T. Curtis, B.J. Aragona, and Z. Wang Social bonding decreases the rewarding properties of amphetamine through a dopamine D1 receptor-mediated mechanism J Neurosci 31 2011 7960 7966
51. E.D. London, S.L. Simon, S.M. Berman, M.A. Mandelkern, A.M. Lichtman, and J. Bramen et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers Arch Gen Psychiatry 61 2004 73 84
52. J.C. McGrath, G.B. Drummond, E.M. McLachlan, C. Kilkenny, and C.L. Wainwright Guidelines for reporting experiments involving animals: the ARRIVE guidelines Br J Pharmacol 160 2010 1573 1576
53. I.S. McGregor, and M.T. Bowen Breaking the loop: oxytocin as a potential treatment for drug addiction Horm Behav 61 2012 331 339
54. I.S. McGregor, P.D. Callaghan, and G.E. Hunt From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol 154 2008 358 368
55. R. McKetin, D.I. Lubman, N.M. Lee, J.E. Ross, and T.N. Slade Major depression among methamphetamine users entering drug treatment programs Med J Aust 195 2011 S51 S55
56. 2A receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain Neuropharmacology 71C 2013 228 236
57. A. Meyer-Lindenberg, G. Domes, P. Kirsch, and M. Heinrichs Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine Nat Rev Neurosci 12 2011 524 538
58. K.C. Morley, J.E. Gallate, G.E. Hunt, P.E. Mallet, and I.S. McGregor Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy") Eur J Pharmacol 433 2001 91 99
59. P. Munzar, Z. Justinova, S.W. Kutkat, S. Ferre, and S.R. Goldberg Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats Psychopharmacology 161 2002 348 355
60. E.A. Phelps, and J.E. LeDoux Contributions of the amygdala to emotion processing: from animal models to human behavior Neuron 48 2005 175 187
61. A.G. Phillips, S. Ahn, and J.G. Howland Amygdalar control of the mesocorticolimbic dopamine system: parallel pathways to motivated behavior Neurosci Biobehav Rev 27 2003 543 554
62. T.A. Ponzio, and G.I. Hatton Adenosine postsynaptically modulates supraoptic neuronal excitability J Neurophysiol 93 2005 535 547
63. T.A. Ponzio, Y.F. Wang, and G.I. Hatton Activation of adenosine A2A receptors alters postsynaptic currents and depolarizes neurons of the supraoptic nucleus Am J Physiol Regul Integr Comp Physiol 291 2006 R359 R366
64. J. Qi, J.Y. Yang, M. Song, Y. Li, F. Wang, and C.F. Wu Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice Naunyn Schmiedebergs Arch Pharmacol 376 2008 441 448
65. J. Qi, J.Y. Yang, F. Wang, Y.N. Zhao, M. Song, and C.F. Wu Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement Neuropharmacology 56 2009 856 865
66. W. Romero-Fernandez, D.O. Borroto-Escuela, L.F. Agnati, and K. Fuxe Evidence for the existence of dopamine D2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor-receptor interactions Mol Psychiatry 2013 10.1038/mp.2012.103 [in press]
67. A.J. Rosenfeld, J.A. Lieberman, and L.F. Jarskog Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia Schizophr Bull 37 2011 1077 1087
68. D.L. Rosin, A. Robeva, R.L. Woodard, P.G. Guyenet, and J. Linden Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system J Comp Neurol 401 1998 163 186
69. Z. Sarnyai Oxytocin and neuroadaptation to cocaine Prog Brain Res 119 1998 449 466
70. Z. Sarnyai Oxytocin as a potential mediator and modulator of drug addiction Addict Biol 16 2011 199 201
71. Z. Sarnyai, M. Vecsernyes, F. Laczi, E. Biro, G. Szabo, and G.L. Kovacs Effects of cocaine on the contents of neurohypophyseal hormones in the plasma and in different brain structures in rats Neuropeptides 23 1992 27 31
72. T. Shimazoe, A. Yoshimatsu, A. Kawashimo, and S. Watanabe Roles of adenosine A(1) and A(2A) receptors in the expression and development of methamphetamine-induced sensitization Eur J Pharmacol 388 2000 249 254
73. M.R. Thompson, K.M. Li, K.J. Clemens, C.G. Gurtman, G.E. Hunt, and J.L. Cornish et al. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA (ÊecstasyÊ) in rats Neuropsychopharmacology 29 2004 694 704
74. M.R. Thompson, P.D. Callaghan, G.E. Hunt, J.L. Cornish, and I.S. McGregor A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy") Neuroscience 146 2007 509 514
75. P.S. van Nieuwenhuijzen, I.S. McGregor, and G.E. Hunt The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen Neuroscience 158 2009 441 455
76. P.S. van Nieuwenhuijzen, L.E. Long, G.E. Hunt, J.C. Arnold, and I.S. McGregor Residual social, memory and oxytocin-related changes in rats following repeated exposure to gamma-hydroxybutyrate (GHB), 3,4- methylenedioxymethamphetamine (MDMA) or their combination Psychopharmacology (Berl) 212 2010 663 674
77. N.D. Volkow, R.D. Baler, and R.Z. Goldstein Addiction: pulling at the neural threads of social behaviors Neuron 69 2011 599 602
78. K. Wada The history and current state of drug abuse in Japan Ann N Y Acad Sci 1216 2011 62 72
79. Z. Wang, D. Toloczko, L.J. Young, K. Moody, J.D. Newman, and T.R. Insel Vasopressin in the forebrain of common marmosets (Callithrix jacchus): studies with in situ hybridization, immunocytochemistry and receptor autoradiography Brain Res 768 1997 147 156
80. R.J. Windle, Y.M. Kershaw, N. Shanks, S.A. Wood, S.L. Lightman, and C.D. Ingram Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity J Neurosci 24 2004 2974 2982
81. W.L. Woolverton, L. Cervo, and C.E. Johanson Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys Pharmacol Biochem Behav 21 1984 737 741
82. J.H. Yoo, I. Kitchen, and A. Bailey The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us? Br J Pharmacol 166 2012 1993 2014
83. A. Yoshimatsu, T. Shimazoe, A. Kawashimo, T. Shuto, Y. Doi, and T. Fukumoto et al. Effects of adenosine A1- and A2A-receptor agonists on enhancement of dopamine release from the striatum in methamphetamine-sensitized rats Jpn J Pharmacol 86 2001 254 257
84. K.A. Young, K.L. Gobrogge, and Z. Wang The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior Neurosci Biobehav Rev 35 2011 498 515